Glucosinolate-rich broccoli microgreen extract promotes osteogenic differentiation and antioxidant responses in human stromal cells: implications for nutraceutical modulation of bone metabolism.
Gambari L., Amore E., Carpentieri S., Di Padua F., Dalle Carbonare LG., Cominacini M.
Laboratory Study on Chronic Inflammation, published in Food Funct (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Food Funct (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42429589
- DOI
- 10.1039/d6fo02085b
Abstract (original English)
Over recent decades, interest in functional foods capable of mitigating age-related disorders and chronic inflammation-associated diseases has markedly increased. Among these, dietary organosulfur compounds, abundantly present in various vegetables, are recognized for their potential preventive effects against multiple pathological conditions. Isothiocyanates and glucosinolates (GLS) derived from Brassicaceae species, most notably sulforaphane and its precursor glucoraphanin, have demonstrated promising potential as adjunctive agents in the management of osteoporosis. Broccoli microgreens are especially rich in GLS; however, their potential application in osteoporosis prevention remains to be conclusively established. The present study sought to evaluate the bioactivity of a GLS-rich methanolic extract derived from broccoli microgreens cultivated under a vertical hydroponic system. Human adipose-derived stromal cells were used as in vitro model. Cellular viability was assessed through lactate dehydrogenase, Alamar blue, and neutral red uptake assays; expression of antioxidant genes was evaluated by real-time PCR. Osteogenic differentiation was investigated via Alizarin Red staining, alkaline phosphatase activity assays, and real-time PCR for osteogenic genes. Our findings indicate that broccoli microgreen extract did not exhibit any significant cytotoxicity up to 100 µM, exerte
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Comparing Regenerative Biologics and Standard Pharmacotherapy for Chronic Rotator Cuff Tendinopathy: A Study of PRP, Cell-Based, and Peptide Interventions
Systematic Review on Tendon Injury, Rotator Cuff, Shoulder Pain, Chronic Inflammation, published in J Orthop Sports Med (2026) — summary generated from the PubMed abstract.
- 2026
J Orthop Sports Med - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level ASystematic ReviewEurope PMC
Exosomes as Cellular Communicators and Therapeutic Agents in Orthopedic Diseases: From Mechanisms to Intervention
Systematic Review on Osteoarthritis, Chronic Inflammation, published in Int J Nanomedicine (2026) — summary generated from the PubMed abstract.
- 2026
Int J Nanomedicine1 citations - Level ASystematic ReviewEurope PMC
Pharmacotherapy agents in prevention and treatment of breast cancer-related lymphedema: a systematic scoping review
Systematic Review on Chronic Inflammation, Immune Modulation, published in Front Oncol (2026) — summary generated from the PubMed abstract.
- 2026
Front Oncol - Level ASystematic ReviewEurope PMC
Trends in peripheral nerve injury research: a bibliometric analysis focused on molecular mechanisms
Systematic Review on Chronic Inflammation, published in Front Neurol (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurol